The Buyout Show with Fexingo · 2026-07-03 · 6 min
Key moments - from our scoring
Substance score
59 / 100
Five dimensions, 20 points each
The dental market has become a quiet but substantial PE consolidation story. Dental Support Organizations - backed by firms like KKR through players like Heartland Dental, which supports over 1,700 practices - acquire the non-clinical infrastructure (buildings, equipment, billing systems) of independent dental practices and lease it back to dentists for 5-12% of revenue. This model emerged as an attractive roll-up thesis after the 2008 recession when fragmented small practices faced debt pressures. The DSO captures value through economies of scale in HR, payroll, supply chain, and marketing while dentists focus on patient care. However, the business model faces mounting scrutiny: the American Dental Association has raised concerns about corporate influence on clinical decisions, some states are considering mandatory majority dentist ownership laws, and whistleblower cases allege unnecessary procedures driven by volume targets. Patient outcomes data is mixed - DSOs standardize care protocols but may push higher patient throughput. With 15% current penetration and demographic tailwinds (average dentist age over 50), analysts project 30-40% market share within a decade, though regulatory headwinds could slow consolidation. For PE operators evaluating dental, the opportunity hinges on state ownership law variations and the willingness of younger dentists (more open to the model) versus established practitioners to cede control.
Approximately 15% of US dentists are now affiliated with DSOs, and private equity deals in dental have totaled well over $10 billion in the past five years.
DSOs acquire non-clinical assets (building, equipment, billing systems) and lease them back to dentists for 5-12% of revenue, centralizing HR, payroll, and supply chain costs; dentists retain clinical control but lose some autonomy, including pressure to see more patients per hour.
Several states are considering laws requiring that a licensed dentist own a majority stake in any dental practice, which would undermine PE's ability to control non-clinical assets.
Younger dentists prefer to focus on clinical work without managing payroll, insurance billing, and hiring, while successful established dentists are reluctant to cede business control.
DSOs standardize care protocols and infection control, but whistleblower cases have alleged unnecessary procedures (such as crowns) driven by volume targets, and studies suggest DSO-affiliated dentists refer more complex cases to specialists.
Our reviewer’s read on each dimension, with quotes from the episode.
The episode packs substantive detail about DSO economics, revenue splits (5-12%), margin comparisons (30% independent vs. lower with DSO overhead), and specific consolidation drivers (2008 recession, retiring dentists). However, it retreats into generalities on quality outcomes and regulatory risk, and the conversation lacks depth on implementation friction, incentive misalignment, or counterarguments to the PE thesis. A B2B operator would learn the fundamentals but not enough to act.
With a DSO, the overhead drops because it's shared across dozens or hundreds of practices.
A typical independent dentist might net 30 percent margin after overhead. With a DSO, the overhead drops because it's shared across dozens or hundreds of practices. The trade-off is they lose some autonomy.
The core narrative - fragmentation + PE + back-office consolidation - is standard private equity playbook language. The DSO-to-hospital-physician-practice analogy is apt but well-worn. The episode covers known tensions (autonomy loss, volume pressure, regulatory risk) without introducing fresh frameworks or counterintuitive takes. A practitioner familiar with PE roll-up mechanics will hear mostly confirmation of existing thesis.
PE firms are essentially betting that the DSO model becomes the default structure for American dentistry, like how hospital systems swallowed up independent physician practices.
the roll-up thesis is: buy the small guys, centralise the back office, and grow earnings before interest, taxes, depreciation, and amortisation - EBITDA - through scale.
Lucas and Luna appear to be podcast hosts or journalists synthesizing publicly available market data and analyst reports, not DSO operators, PE dentistry investors, or frontline practitioners with operating experience. They speak knowledgeably but at one remove; neither has direct deal experience or internal visibility into DSO operations, incentive structures, or post-acquisition friction. The conversation lacks the specificity that comes from having run or invested in the model.
I've seen the numbers - roughly 15 percent of US dentists are now affiliated with some kind of DSO.
I've seen analysts project 30 to 40 percent penetration in the next decade.
Good anchors: 15% current DSO penetration, 5-12% revenue split, 30% independent margins, Heartland Dental (1,700+ practices, KKR backing), 200,000 total US dentists, $10B+ in PE dental deals over 5 years, 20% revenue growth from service upsells, 50+ average dentist age. However, analyst projections (30-40% ceiling) lack source attribution, and quality/whistleblower claims are vague ('a few years back,' 'allegedly'). Missing: actual EBITDA multiples, hold periods, exit data, or specific DSO failure cases.
roughly 15 percent of US dentists are now affiliated with some kind of DSO.
A typical independent dentist might net 30 percent margin after overhead.
Lucas and Luna take turns driving points, follow each other logically, and flag counterarguments (state ownership laws, quality concerns, younger dentist resistance). However, questioning lacks teeth: no pushback on whether DSOs actually improve margins, no interrogation of the $10B figure or analyst projections, no exploration of failed DSOs or PE exit dynamics. The exchange feels like co-reporting rather than debate. Luna's patient-outcome question is good but gets a soft 'it's mixed' answer that isn't challenged.
But there's pushback. The American Dental Association has raised concerns about corporate influence on clinical decisions.
And the penetration - 15 percent - suggests there's room to grow. What's the ceiling?
Computed from the transcript - who did the talking, and the words that came up most.
Private equity has rolled up thousands of dental practices into Dental Support Organizations, or DSOs. In this episode, Lucas and Luna break down the specific financial model: how a DSO takes the back-office costs off a dentist's hands in exchange for a cut of revenue, why PE firms love the recurring patient base, and why roughly 15 percent of US dentists now work under some DSO agreement. They examine the case of Heartland Dental, one of the largest DSOs with over 1,700 supported practices, and discuss the tension between clinical autonomy and operational efficiency. Lucas also shares why some dentists are pushing back against six-patient-per-hour quotas, and what it means for patient care. The episode closes with a look at whether the DSO model can scale past the current 20 percent market penetration before hitting regulatory or cultural limits. A behind-the-scenes segment briefly notes that listener support via buy me a coffee dot com slash fexingo keeps this podcast ad-free.
Transcribed and scored by The B2B Podcast Index.
Lucas: So last week I was at a conference and I kept hearing the term DSO - Dental Support Organization. And I realised I actually didn't have a clear picture of how private equity has been rolling up dental practices. Turns out it's a massive, quiet wave. Luna: I've seen the numbers - roughly 15 percent of US dentists are now affiliated with some kind of DSO.
But the model itself is pretty opaque to most patients. Lucas: Right. The patient walks in, they see the same dentist, maybe a new sign on the door. But behind the scenes, a PE firm has bought the practice's non-clinical assets - the building, the equipment, the billing system - and they lease it back to the dentist.
The dentist keeps clinical control, but the DSO takes a cut of revenue, usually somewhere between 5 and 12 percent. Luna: And that cut pays for centralised services - HR, payroll, marketing, supply chain. The dentist gets to focus on drilling and filling, not on hiring a receptionist. Lucas: Exactly.
The economics are compelling. A typical independent dentist might net 30 percent margin after overhead. With a DSO, the overhead drops because it's shared across dozens or hundreds of practices. The trade-off is they lose some autonomy.
The DSO might push them to see six patients per hour instead of four, and that's where the tension lives. Luna: Let's talk about the poster child. Heartland Dental - backed by KKR and others - they support over 1,700 practices across the US. That's a lot of buying power on supplies alone.
Lucas: Heartland is the biggest, but there are dozens. The model really took off after the 2008 recession. Dentists were retiring or struggling with debt, and PE firms saw a fragmented market ripe for consolidation. There are roughly 200,000 dentists in the US, and most practices are still single-location.
So the roll-up thesis is: buy the small guys, centralise the back office, and grow earnings before interest, taxes, depreciation, and amortisation - EBITDA - through scale. Luna: And the revenue is sticky. People need dental care - cleanings, fillings, root canals - it's not discretionary like cosmetic surgery. So the recurring patient base is a big draw for PE.
Lucas: Right. A DSO can also upsell - things like whitening, Invisalign, implants. So same patient, higher average ticket. Some DSOs have reported 20 percent revenue growth just from adding services.
Luna: But there's pushback. The American Dental Association has raised concerns about corporate influence on clinical decisions. And a few states have considered laws requiring that a licensed dentist own a majority stake in any practice. Lucas: That's the big regulatory risk.
If states start capping non-dentist ownership, the PE model gets complicated. So far, only a handful of states have moved in that direction, but it's worth watching. Luna: What about the numbers on patient outcomes? I've seen some studies suggesting dso affiliated dentists perform fewer complex procedures and refer more out to specialists.
Is that a quality concern? Lucas: It's mixed. On one hand, DSOs standardise care - you get consistent infection control, digital X-rays, that sort of thing. On the other hand, the pressure to hit volume targets can lead to over-treatment or rushed work.
There was a whistleblower case a few years back where a DSO allegedly pushed dentists to perform unnecessary crowns. So the jury is out. Luna: But the market clearly sees value. Private equity deals in dental have totalled well over $10 billion in the past five years.
And the penetration - 15 percent - suggests there's room to grow. What's the ceiling? Lucas: I've seen analysts project 30 to 40 percent penetration in the next decade. But I think it'll slow once the easy targets - retiring solo practitioners - are bought up.
The harder sell is convincing younger, successful dentists to give up control. Luna: Yeah, the younger generation actually seems more open to it. They don't want to run a business; they want to practice dentistry without the headache of payroll and insurance billing. So maybe the ceiling is higher than we think.
Lucas: Good point. And there's a demographic tailwind: the average dentist is over 50, so a lot of practices will change hands in the next decade. PE firms are essentially betting that the DSO model becomes the default structure for American dentistry, like how hospital systems swallowed up independent physician practices. Luna: Quick honest thing - a handful of listeners chip in monthly through buy me a coffee dot com slash fexingo, and that's literally what funds making deep-dive episodes like this.
No ads, no sponsors - just the audience. Lucas: Yeah, if these conversations have moved your work forward in some small way, that's where it comes from. Appreciate everyone who's part of that. Luna: So back to dentistry - what's the one concrete number listeners should remember from this episode?
Lucas: I'd say 15 percent. That's the slice of the US dental market currently under DSO management. If you're in PE, that's the arrow on the chart that says 'room to run.' And if you're a patient, next time you're in the chair, you might ask: is this practice dso affiliated?
The answer might tell you something about the business behind the drill. Luna: That's a good closing thought. And we'll keep watching how the regulatory landscape evolves - especially those state ownership laws. Lucas: Exactly.
Thanks for listening.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
What Private Equity Looks For Before They Buy with Wayne Marhelski (#79)Exit Algorithms · on EBITDA91 / 100
The Invisible Line Between VP and C-Suite Success with Andrea KayalPillar Talk · on EBITDA86 / 100
Route 101 On Building Resilient Businesses Through Uncertain TimesStartup Builders & Backers · on Recurring revenue models81 / 100
How Private Equity Is Buying Up Pet Cremation ServicesPrivate Equity Conversations with Fexingo · on KKR80 / 100
Episode 39: India’s Infrastructure Evolution: Unlocking Private Capital at ScaleTalking Global Infrastructure · on KKR77 / 100
From Broadway to Exit: A Performer’s Path to Impact Investing with Lisa Morris, Founder of Road Concierge and Managing Director of AKS Family Partners3i Member Spotlight · on EBITDA69 / 100
How Private Equity Is Buying Up Dog Daycares84 / 100How Private Equity Is Buying Up Plumbing and HVAC Contractors79 / 100How Private Equity Is Buying Up Urgent Care Centers92 / 100How Private Equity Is Buying Up College Dormitories83 / 100How Private Equity Is Buying Up Hemp and CBD Companies80 / 100